Salvia divinorum: exposures reported to a statewide poison control system over 10 years
- PMID: 19765944
- DOI: 10.1016/j.jemermed.2009.05.019
Salvia divinorum: exposures reported to a statewide poison control system over 10 years
Abstract
Background: Salvia divinorum, a hallucinogenic herb, has in recent years become popular among teenagers and young adults. Salvia is presently marketed as a "legal" alternative to other drugs of abuse, but little is known about the clinical toxicity of this substance.
Objectives: The purpose of this study is to describe the clinical and demographic features of this emerging substance of recreational abuse using data obtained from the records of a poison control center.
Methods: We performed retrospective review of exposures to the herbal hallucinogen Salvia divinorum as reported to the California Poison Control System (CPCS) over the last 10 years. Demographic and clinical data were collected and compiled from the computerized records of the CPCS for the search terms "salvia" and "sage."
Results: There were 37 exposures to S. divinorum and 96 exposures to non-hallucinogenic Salvia species. Eighteen (49%) of the exposures were to S. divinorum alone. Intentional Salvia exposures resulted in a variety of neurologic, cardiovascular, and gastrointestinal effects. Notably, the use of concomitant substances of abuse was associated with a high rate of complications and psychomotor disturbances.
Conclusions: Intentional use of S. divinorum, whether alone or in combination with alcoholic beverages and other drugs, causes neurologic, cardiovascular, and gastrointestinal effects. This poison-center-based review helps to characterize the clinical toxicity of S. divinorum, but more clinical and pharmacologic research is warranted for this rapidly emerging substance of abuse.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Peyote and mescaline exposures: a 12-year review of a statewide poison center database.Clin Toxicol (Phila). 2010 May;48(4):350-3. doi: 10.3109/15563650903586745. Clin Toxicol (Phila). 2010. PMID: 20170392
-
Human bromethalin exposures reported to a U.S. Statewide Poison Control System.Clin Toxicol (Phila). 2016 Mar;54(3):277-81. doi: 10.3109/15563650.2016.1139713. Epub 2016 Feb 9. Clin Toxicol (Phila). 2016. PMID: 26860212
-
Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug.Hum Psychopharmacol. 2013 Sep;28(5):403-12. doi: 10.1002/hup.2304. Epub 2013 Jun 23. Hum Psychopharmacol. 2013. PMID: 23794315 Review.
-
Tramadol exposures reported to statewide poison control system.Ann Pharmacother. 2005 Jun;39(6):1039-44. doi: 10.1345/aph.1E577. Epub 2005 May 3. Ann Pharmacother. 2005. PMID: 15870139
-
The Association of Salvia divinorum and Psychotic Disorders: A Review of the Literature and Case Series.J Psychoactive Drugs. 2015 Sep-Oct;47(4):286-92. doi: 10.1080/02791072.2015.1073815. Epub 2015 Aug 28. J Psychoactive Drugs. 2015. PMID: 26317561 Review.
Cited by
-
Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.J Med Toxicol. 2012 Mar;8(1):15-32. doi: 10.1007/s13181-011-0202-2. J Med Toxicol. 2012. PMID: 22271566 Free PMC article. Review.
-
Use of Salvia divinorum in a nationally representative sample.Am J Drug Alcohol Abuse. 2012 Jan;38(1):108-13. doi: 10.3109/00952990.2011.600397. Epub 2011 Aug 11. Am J Drug Alcohol Abuse. 2012. PMID: 21834614 Free PMC article.
-
Salvinorin A and Salvia divinorum: Toxicology, Pharmacological Profile, and Therapeutic Potential.Int J Mol Sci. 2025 Jun 11;26(12):5588. doi: 10.3390/ijms26125588. Int J Mol Sci. 2025. PMID: 40565052 Free PMC article. Review.
-
A Report of Nausea and Vomiting with Discontinuation of Chronic Use of Salvia divinorum.Case Rep Med. 2012;2012:543747. doi: 10.1155/2012/543747. Epub 2012 May 7. Case Rep Med. 2012. PMID: 22611407 Free PMC article.
-
Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.Biol Psychiatry. 2012 Nov 15;72(10):871-9. doi: 10.1016/j.biopsych.2012.06.012. Epub 2012 Jul 18. Biol Psychiatry. 2012. PMID: 22817868 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources